Published in Ann Vasc Surg on May 24, 2006
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev (2011) 1.74
Thrombelastography guides transfusion strategy. Int J Biomed Sci (2009) 0.78
Prognostic index for adult patients with acute myeloid leukemia in first relapse. J Clin Oncol (2005) 3.15
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma. J Clin Oncol (2008) 2.32
High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study. J Clin Oncol (2013) 2.22
The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands. Leuk Res (2012) 2.18
Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. Br J Haematol (2010) 1.66
Reduction in diabetes-related lower-extremity amputations in The Netherlands: 1991-2000. Diabetes Care (2004) 1.62
18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review. Haematologica (2006) 1.61
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial. Blood (2007) 1.60
Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography. Eur J Nucl Med Mol Imaging (2006) 1.58
Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON-SAKK co-operative group studies. Br J Haematol (2005) 1.54
Endovascular repair versus open repair of ruptured abdominal aortic aneurysms: a multicenter randomized controlled trial. Ann Surg (2013) 1.50
Long-term follow-up of tandem autologous stem-cell transplantation in multiple myeloma. J Clin Oncol (2010) 1.48
Thoracic sympathectomy: effects on hemodynamics and baroreflex control. Clin Auton Res (2002) 1.47
Palifermin and palmar-plantar erythrodysesthesia. Br J Haematol (2007) 1.45
Motives for (not) participating in a lifestyle intervention trial. BMC Med Res Methodol (2008) 1.33
Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood (2006) 1.31
Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET. Eur J Nucl Med Mol Imaging (2012) 1.21
Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic. Br J Haematol (2002) 1.11
Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Med (2006) 1.07
Autologous peripheral blood stem cell transplantation for acute myeloid leukemia. Blood (2011) 1.01
Proteoglycans guide SDF-1-induced migration of hematopoietic progenitor cells. J Leukoc Biol (2002) 1.01
Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy. Br J Clin Pharmacol (2012) 0.96
Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. Nephrol Dial Transplant (2003) 0.95
Emergency endovascular treatment for ruptured abdominal aortic aneurysm and the risk of spinal cord ischemia. J Vasc Surg (2005) 0.92
Inhibition of Rho-ROCK signaling induces apoptotic and non-apoptotic PS exposure in cardiomyocytes via inhibition of flippase. J Mol Cell Cardiol (2010) 0.91
Hybrid treatment of a ruptured diverticulum of Kommerell. J Endovasc Ther (2010) 0.90
N(omega)-(carboxymethyl)lysine depositions in human aortic heart valves: similarities with atherosclerotic blood vessels. Atherosclerosis (2004) 0.89
Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans. Nephrol Dial Transplant (2002) 0.87
Physical exercise interventions in haematological cancer patients, feasible to conduct but effectiveness to be established: a systematic literature review. Cancer Treat Rev (2008) 0.86
Surgeon's volume is not associated with complication outcome after laparoscopic cholecystectomy. Dig Dis Sci (2013) 0.86
The flux of arginine after ischemia-reperfusion in the rat kidney. Kidney Int (2002) 0.85
Amyloidosis of the tongue as a paraneoplastic marker of plasma cell dyscrasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2002) 0.84
Homocysteine affects cardiomyocyte viability: concentration-dependent effects on reversible flip-flop, apoptosis and necrosis. Apoptosis (2007) 0.84
Early apoptosis largely accounts for functional impairment of CD34+ cells in frozen-thawed stem cell grafts. J Hematother Stem Cell Res (2002) 0.84
Robot-assisted laparoscopic aortobifemoral bypass for aortoiliac occlusive disease: a report of two cases. J Vasc Surg (2002) 0.84
Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with ⁹⁰Yttrium ibritumomab tiuxetan-BEAM and autologous stem cell transplantation. Br J Haematol (2012) 0.83
Novel applications of therapeutic hypothermia: report of three cases. Crit Care (2004) 0.83
Hemodynamic changes in ipsi- and contralateral cerebral arterial territories after carotid endarterectomy using positron emission tomography. Surg Neurol (2008) 0.82
Practical feasibility of outcomes research in oncology: lessons learned in assessing drug use and cost-effectiveness in The Netherlands. Eur J Cancer (2012) 0.82
Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patients. World J Gastroenterol (2008) 0.82
Plasma ADMA concentrations at birth and mechanical ventilation in preterm infants: a prospective pilot study. Pediatr Pulmonol (2008) 0.82
Cost-effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population-based study. Eur J Haematol (2014) 0.82
Homocysteine-induced apoptosis in endothelial cells coincides with nuclear NOX2 and peri-nuclear NOX4 activity. Cell Biochem Biophys (2013) 0.82
Reinfusion of unprocessed, granulocyte colony-stimulating factor-stimulated whole blood allows dose escalation of 186Relabeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I dose escalation study. Clin Cancer Res (2002) 0.81
Bone marrow stromal proteoglycans regulate megakaryocytic differentiation of human progenitor cells. Exp Cell Res (2004) 0.81
In vitro model for hematopoietic progenitor cell homing reveals endothelial heparan sulfate proteoglycans as direct adhesive ligands. J Leukoc Biol (2003) 0.81
S-Adenosylhomocysteine induces apoptosis and phosphatidylserine exposure in endothelial cells independent of homocysteine. Atherosclerosis (2011) 0.80
Collective experience with hybrid procedures for suprarenal and thoracoabdominal aneurysms. Vascular (2008) 0.80
Suture damage during robot-assisted vascular surgery: is it an issue? Surg Laparosc Endosc Percutan Tech (2007) 0.79
Distress and quality of life after autologous stem cell transplantation: a randomized clinical trial to evaluate the outcome of a web-based stepped care intervention. BMC Cancer (2010) 0.79
Economic assessment on the management of chronic lymphocytic leukaemia. Expert Opin Pharmacother (2005) 0.79
Thoracic sympathectomy for digital ischemia: a summary of evidence. J Vasc Surg (2011) 0.78
Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia. Liver Int (2004) 0.78
Cognitive coping style (monitoring and blunting) and the need for information, information satisfaction and shared decision making among patients with haematological malignancies. Psychooncology (2014) 0.78
The effect of a comprehensive lifestyle intervention on cardiovascular risk factors in pharmacologically treated patients with stable cardiovascular disease compared to usual care: a randomised controlled trial. BMC Cardiovasc Disord (2012) 0.78
Transit-time volume flow measurements in autogenous femorodistal bypass surgery for intraoperative quality control. Vascular (2010) 0.78
Endovascular repair of a type B aortic dissection with transposition of a coexistent aberrant subclavian (lusorian) artery. J Endovasc Ther (2002) 0.78
Homocysteine-induced cardiomyocyte apoptosis and plasma membrane flip-flop are independent of S-adenosylhomocysteine: a crucial role for nuclear p47(phox). Mol Cell Biochem (2011) 0.77
Health-related quality of life and persistent symptoms in relation to (R-)CHOP14, (R-)CHOP21, and other therapies among patients with diffuse large B-cell lymphoma: results of the population-based PHAROS-registry. Ann Hematol (2014) 0.77
Carotid artery dynamics during head movements: a reason for concern with regard to carotid stenting? J Endovasc Ther (2003) 0.77
Carotid stent mobility with regard to head movements: in vitro analysis. Vascular (2005) 0.77
Homing and clonogenic outgrowth of CD34(+) peripheral blood stem cells: a role for L-selectin? Exp Hematol (2002) 0.77
18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma. Br J Haematol (2003) 0.77
Costs of multiple myeloma and associated skeletal-related events in The Netherlands. Expert Rev Pharmacoecon Outcomes Res (2004) 0.77
Monoclonal antibody therapy in haematological malignancies. Curr Clin Pharmacol (2010) 0.76
Reduced supportive capacity of bone marrow stroma upon chemotherapy is mediated via changes in glycosaminoglycan profile. Matrix Biol (2007) 0.76
Homocysteine induces phosphatidylserine exposure in cardiomyocytes through inhibition of Rho kinase and flippase activity. Cell Physiol Biochem (2011) 0.76
Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 x 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphoma. Br J Haematol (2002) 0.76
Cefpirome as empirical treatment for febrile neutropenia in patients with hematologic malignancies. Haematologica (2005) 0.75
Autologous Stem Cell Transplantation in elderly Acute Myeloid Leukemia. Mediterr J Hematol Infect Dis (2013) 0.75
In vitro safety profile of G-CSF-mobilized whole blood after storage for 7 days in an infusable-grade L15 medium. Transfusion (2002) 0.75
[Monoclonal B-cell lymphocytosis: physiological entity or preliminary stage of chronic lymphocytic leukaemia?]. Ned Tijdschr Geneeskd (2010) 0.75
Cost analysis of common treatment options for indolent follicular non-Hodgkin's lymphoma. Haematologica (2005) 0.75
Radiation therapy in early stage Hodgkin's disease: long-term results and adverse effects. Hematol J (2002) 0.75
Modular branched endograft system for aortic aneurysm repair: evaluation in a human cadaver circulation model. Vasc Endovascular Surg (2007) 0.75
A temporary hemostatic valve in the short limb of a bifurcated stent-graft to facilitate endovascular repair of ruptured aortic aneurysm: experimental findings. J Endovasc Ther (2005) 0.75
Implantable defibrillators in cardiac amyloidosis. Int J Cardiol (2012) 0.75
Perceived need for information of patients with haematological malignancies: a literature review. J Clin Nurs (2014) 0.75
Textbook Outcome: A Composite Measure for Quality of Elective Aneurysm Surgery. Ann Surg (2017) 0.75
Platelet activation during haemodialysis: comparison of cuprammonium rayon and polysulfone membranes. Blood Purif (2007) 0.75
Fenestrated and branched endografts: assessment of proximal aortic neck fixation. J Endovasc Ther (2005) 0.75
[Guideline 'Diagnosis and treatment of abdominal aortic aneurysm']. Ned Tijdschr Geneeskd (2009) 0.75
Small popliteal artery aneurysms: important clinical consequences and contralateral survey in daily vascular surgery practice. Ann Vasc Surg (2013) 0.75
Long-term outcome of popliteal artery aneurysms after ligation and bypass. Vasc Endovascular Surg (2011) 0.75
[Allogenic stem cell transplantation in the Netherlands]. Ned Tijdschr Geneeskd (2009) 0.75
How to exclude the dilated false lumen in patients after a type B aortic dissection? The cork in the bottleneck. J Endovasc Ther (2003) 0.75
Radioimmunotherapy for indolent B-cell non-Hodgkin lymphoma in relapsed, refractory and transformed disease. BioDrugs (2006) 0.75
Emerging antibody-targeted therapy in leukemia and lymphoma: current concepts and clinical implications. Anticancer Drugs (2004) 0.75
Effects of cyclosporine a on single-dose pharmacokinetics of intravenous itraconazole in patients with hematologic malignancies. Ther Drug Monit (2008) 0.75
Long-term quality of life and mobility after prosthetic above-the-knee bypass surgery. Ann Vasc Surg (2011) 0.75
Antibody-targeted therapy: a paradigm of innovative treatment strategies in indolent and aggressive B-cell non-Hodgkin lymphoma. Curr Opin Hematol (2004) 0.75
Aortoiliac reconstruction for abdominal aortic rupture after blunt trauma. J Trauma (2009) 0.75
False lumen thrombectomy of the superior mesenteric artery followed by iliomesenteric bypass after Stanford type B aortic dissection. Vascular (2005) 0.75
Cine MRI assessment of aortic aneurysm dynamics before and after endovascular repair. J Endovasc Ther (2003) 0.75